Healthcare Professionals’ Perceptions About Medical Cannabis in Greece: A Qualitative Study DOI Creative Commons
Christos Ntais, Yioula Melanthiou, Μichael A. Talias

et al.

Journal of Market Access & Health Policy, Journal Year: 2025, Volume and Issue: 13(2), P. 13 - 13

Published: April 2, 2025

Background: Medical cannabis continues to generate interest as a potential therapeutic option, yet its acceptance in clinical practice faces challenges, including regulatory barriers, social stigma, and gaps scientific evidence. Methods: This study explores the perspectives of Greek medical doctors pharmacists on cannabis—key stakeholders application—through semi-structured interviews with 12 participants from each profession. Results: expressed range views cannabis, many acknowledging while emphasizing need for rigorous, disease-specific research. highlighted lack consistent trials, concerns about drug interactions, fine line between use misuse. Pharmacists echoed these concerns, citing inconsistencies standardized dosing. Both groups agreed that stigma misinformation hinder adoption, advocating targeted education transparent research communication. Participants indicated barriers also pose calls harmonized policies phased market entry approaches. Effective communication strategies, digital outreach clear messaging, were suggested differentiate recreational improve trust among healthcare providers patients. urgent collaboration policymakers, researchers, professionals establish credible option. Conclusion: The insights gained provide actionable recommendations bridge existing emphasize responsible, evidence-based approach

Language: Английский

Healthcare Professionals’ Perceptions About Medical Cannabis in Greece: A Qualitative Study DOI Creative Commons
Christos Ntais, Yioula Melanthiou, Μichael A. Talias

et al.

Journal of Market Access & Health Policy, Journal Year: 2025, Volume and Issue: 13(2), P. 13 - 13

Published: April 2, 2025

Background: Medical cannabis continues to generate interest as a potential therapeutic option, yet its acceptance in clinical practice faces challenges, including regulatory barriers, social stigma, and gaps scientific evidence. Methods: This study explores the perspectives of Greek medical doctors pharmacists on cannabis—key stakeholders application—through semi-structured interviews with 12 participants from each profession. Results: expressed range views cannabis, many acknowledging while emphasizing need for rigorous, disease-specific research. highlighted lack consistent trials, concerns about drug interactions, fine line between use misuse. Pharmacists echoed these concerns, citing inconsistencies standardized dosing. Both groups agreed that stigma misinformation hinder adoption, advocating targeted education transparent research communication. Participants indicated barriers also pose calls harmonized policies phased market entry approaches. Effective communication strategies, digital outreach clear messaging, were suggested differentiate recreational improve trust among healthcare providers patients. urgent collaboration policymakers, researchers, professionals establish credible option. Conclusion: The insights gained provide actionable recommendations bridge existing emphasize responsible, evidence-based approach

Language: Английский

Citations

0